The INFORMS Analytics+ Conference showcased how companies are turning advanced analytics and AI into measurable operational results
Museums take this educational role seriously, and many institutions understand the need to sustain and broaden their appeal. “They used to be these big ivory towers of knowledge and history and thought and art,” said Hilary Knight, director of Change& in London and former director of digital at Tate. “Museums themselves are changing their role to be centers for discussion and encounter and to be much more participatory.”
American teenagers start their school day too early.
Medical experts have been clear for years: sleep cycle changes during puberty make it hard for teenagers to learn in the early morning. Later school start times have been linked to better sleep, improved mental health, stronger academic performance and even safer driving.
Most school district leaders know about this problem and care about fixing it. But changing the schedule can feel operationally impossible.
An audio journey of how data and analytics save lives, save money and solve problems.
Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
Food banks are struggling to meet record demands, but with millions of Americans out of work, record amounts of perfectly good food are being thrown away. KTVU's Tom Vacar looks at the food supply chain and some of its logistical problems.
We have just a few weeks to plan for our best and possibly only way to stop this pandemic before it destroys our economy and health care system.
What-if questions can torment a doctor making coronavirus retest decisions: What if a patient’s initial negative test was a false negative, and he or she needs a second test? What if they don’t need it, and a retest would use up a scarce test kit and treatments that other patients need?
Abbott will deliver 50,000 COVID-19 tests per day to healthcare workers, starting Wednesday, using its modified ID NOW testing process, it said. Bringing rapid coronavirus testing capacity to the medical front lines is crucial in the battle to flatten the rising death and infection curve worldwide.
Gilead has asked the Food and Drug Administration to rescind a special regulatory status for its experimental coronavirus drug, but not before stirring up a controversy that had critics accusing the company of manipulating a law designed to spur research into therapies for rare diseases.
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine